atazanavir sulfate has been researched along with artesunic acid in 2 studies
| Studies (atazanavir sulfate) | Trials (atazanavir sulfate) | Recent Studies (post-2010) (atazanavir sulfate) | Studies (artesunic acid) | Trials (artesunic acid) | Recent Studies (post-2010) (artesunic acid) |
|---|---|---|---|---|---|
| 1,102 | 246 | 590 | 2,089 | 443 | 1,182 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauer, JW; Breitenbach, M; Breitenbach-Koller, H; Friedrich, A; Hintner, H; Karl, T; Kitzler, CM; Krauß, J; Lottspeich, F; Mewes, W; Müller, N; Rathner, A; Rathner, P; Schernthaner, J; von Hagen, J; Wießner, M | 1 |
| Tsanni, A | 1 |
2 other study(ies) available for atazanavir sulfate and artesunic acid
| Article | Year |
|---|---|
Drug Development for Target Ribosomal Protein rpL35/uL29 for Repair of LAMB3R635X in Rare Skin Disease Epidermolysis Bullosa.
Topics: Artesunate; Atazanavir Sulfate; Cell Adhesion Molecules; Epidermolysis Bullosa, Junctional; Humans; Kalinin; Molecular Docking Simulation; Protein Binding; Ribosomal Proteins; RNA, Messenger; Skin; Skin Physiological Phenomena | 2021 |
African scientists race to test COVID drugs - but face major hurdles.
Topics: Africa; Amides; Amodiaquine; Artesunate; Atazanavir Sulfate; Carbamates; Clinical Trials as Topic; COVID-19; COVID-19 Drug Treatment; COVID-19 Vaccines; Cytidine; Drug Approval; Drug Evaluation, Preclinical; Drug Repositioning; Drug Therapy, Combination; Humans; Hydroxylamines; Imidazoles; Ivermectin; Naphthyridines; Nitro Compounds; Pregnenediones; Pyrazines; Pyrrolidines; Ritonavir; Sample Size; Thiazoles; Valine; World Health Organization | 2021 |